Šalis: Naujoji Zelandija
kalba: anglų
Šaltinis: Ministry for Primary Industries
pimobendan; benazepril hydrochloride
Elanco Australasia Pty Ltd
benazepril hydrochloride, pimobendan
pimobendan 3.76 g/kg; benazepril hydrochloride 150.38 g/kg
Cardiovascular agent
ACVM Registered
2016-02-23
COMPANY CONFIDENTIAL PRODUCT NAME: Fortekor Plus 1.25 mg/2.5 mg, Fortekor Plus 5 mg/10 mg REVISION DATE: 07 Jun 2019 PAGE: 1 of 7 PACK SIZES: Not sold TYPE OF LABEL: blister, leaflet and carton PREPARED BY: Yan Er COUNTRY: NZ REASON: MAT Text above this line is not included in the actual label. GENERIC PRODUCT NAME: VERSION: REVISION DATE ACVM CODE Fortekor plus 1.25/2.5 & 5/10 mg FINAL 07 Jun 2019 A011169 & A011170 COPYRIGHT © 2019 ELANCO OR ITS AFFILIATES _BLISTER _ FOR ANIMAL TREATMENT ONLY FORTEKOR PLUS 1.25 MG/2.5 MG TABLETS FOR DOGS PIMOBENDAN/BENAZEPRIL HYDROCHLORIDE (FORTEKOR PLUS 5 MG/10 MG TABLETS FOR DOGS PIMOBENDAN/BENAZEPRIL HYDROCHLORIDE) Elanco Logo Lot: Exp: COMPANY CONFIDENTIAL PRODUCT NAME: Fortekor Plus 1.25 mg/2.5 mg, Fortekor Plus 5 mg/10 mg REVISION DATE: 07 Jun 2019 PAGE: 2 of 7 PACK SIZES: Not sold TYPE OF LABEL: blister, leaflet and carton PREPARED BY: Yan Er COUNTRY: NZ REASON: MAT Text above this line is not included in the actual label. GENERIC PRODUCT NAME: VERSION: REVISION DATE ACVM CODE Fortekor plus 1.25/2.5 & 5/10 mg FINAL 07 Jun 2019 A011169 & A011170 COPYRIGHT © 2019 ELANCO OR ITS AFFILIATES _CARTON – FRONT AND REAR PANEL _ PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY FORTEKOR PLUS 1.25 MG PIMOBENDAN/2.5 MG BENAZEPRIL HCL TABLETS FOR DOGS (FORTEKOR PLUS 5 MG PIMOBENDAN/10 MG BENAZEPRIL HCL TABLETS FOR DOGS) ACTIVE CONSTITUENTS: EACH TABLET CONTAINS 1.25 MG PIMOBENDAN (5 MG PIMOBENDAN) 2.5 MG BENAZEPRIL HYDROCHLORIDE (10 MG BENAZEPRIL HYDROCHLORIDE) For the treatment of congestive heart failure due to atrioventricular valve insufficiency or dilated cardiomyopathy in dogs. 30 tablets (60 tablets) (5 mg/10 mg 30 tablets; 60 tablets) READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE DO NOT USE IN CASES OF HYPOTENSION, HYPOVOLEMIA OR ACUTE RENAL FAILURE. DO NOT USE IN DOGS WITH HYPERTROPHIC CARDIOMYOPATHY OR IN CASES OF CARDIAC OUTPUT FAILURE DUE TO AORTIC OR PULMONARY STENOSIS. DOSAGE AND ADMINISTRATION Daily oral admi Perskaitykite visą dokumentą